ストックスクリーナーアプリを入手
0.67
12.02%
0.0719
アフターアワーズ：
.61
-0.06
-8.96%
前日終値:
$0.5981
開ける：
$0.66
24時間の取引高:
18,220
Relative Volume:
0.57
時価総額：
$4.29M
収益：
-
当期純損益:
$-21.13M
株価収益率:
-0.1399
EPS:
-4.79
ネットキャッシュフロー:
$-16.95M
1週間 パフォーマンス:
+14.33%
1か月 パフォーマンス:
-15.19%
6か月 パフォーマンス:
-27.17%
1年 パフォーマンス:
-30.19%
1日の値動き範囲:
$0.6209
$0.68
1週間の範囲:
$0.562
$0.68
52週間の値動き範囲:
$0.4748
$3.09
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
名前
Matinas Biopharma Holdings Inc
セクター
電話
908-443-1860
住所
1545 Route 206 South, Suite 302, Bedminster, NJ
MTNB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
0.67 | 3.83M | 0 | -21.13M | -16.95M | -4.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-05-11 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | 再開されました | Piper Sandler | Overweight |
| 2020-01-27 | 開始されました | Piper Sandler | Overweight |
| 2020-01-24 | 開始されました | SunTrust | Buy |
| 2020-01-23 | 開始されました | SunTrust | Buy |
| 2020-01-09 | 開始されました | Aegis Capital | Buy |
| 2019-06-26 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Matinas Biopharma Holdings Inc (MTNB) 最新ニュース
Holdings Limited RecoverySwing Trading Watchlist & Free Navigate Market With Precision - bollywoodhelpline.com
Will Matinas BioPharma Holdings Inc. (6LJ0) stock sustain uptrend momentumPortfolio Return Report & High Conviction Investment Ideas - Улправда
Can Matinas BioPharma Holdings Inc. stock beat market expectations this quarter2025 Big Picture & Verified Trade Idea Suggestions - Улправда
Breakout Watch: Can Matinas BioPharma Holdings Inc. stock beat market expectations this quarterPortfolio Performance Report & Capital Efficiency Focused Ideas - Улправда
Will Matinas BioPharma Holdings Inc. stock deliver strong dividend growthPortfolio Return Summary & AI Forecasted Stock Moves - bolumsonucanavari.com
Is Matinas BioPharma Holdings Inc. stock supported by innovation pipelinePortfolio Value Report & Real-Time Sentiment Analysis - DonanımHaber
Trading Recap: Will Matinas BioPharma Holdings Inc. stock benefit from sector rotationJuly 2025 Volume & Weekly High Momentum Picks - ulpravda.ru
Matinas BioPharma amends CEO employment agreement to revise retention bonus terms - Investing.com Canada
Matinas BioPharma Amends CEO Employment Agreement - The Globe and Mail
Matinas BioPharma amends CEO employment agreement to revise retention bonus terms By Investing.com - Investing.com South Africa
Matinas BioPharma (NYSE: MTNB) amends CEO contract with extended change-in-control bonus protections - Stock Titan
Matinas BioPharma CFO Resignation Announced - MSN
Forecast Cut: Will Matinas BioPharma Holdings Inc stock gain from strong economyMarket Rally & AI Enhanced Market Trend Forecasts - BỘ NỘI VỤ
How Matinas Biopharma Holdings Inc. stock reacts to stronger dollarJuly 2025 Sentiment & Free Risk Controlled Daily Trade Plans - Newser
What insider trading reveals about Matinas BioPharma Holdings Inc. stockQuarterly Market Review & Accurate Buy Signal Notifications - Newser
Why Matinas Biopharma Holdings Inc. stock attracts wealthy investorsPortfolio Gains Report & Proven Capital Preservation Methods - Newser
Will Matinas BioPharma Holdings Inc. stock gain from strong economyEarnings Beat & Free Low Drawdown Momentum Trade Ideas - Newser
Will Matinas Biopharma Holdings Inc. stock sustain uptrend momentum2025 Year in Review & Fast Entry and Exit Trade Plans - Newser
How Matinas BioPharma Holdings Inc. (6LJ0) stock reacts to new regulationsTake Profit & Intraday High Probability Setup Alerts - Newser
Is Matinas Biopharma Holdings Inc. stock a top hedge fund pickOil Prices & High Return Trade Opportunity Guides - Newser
Why Matinas Biopharma Holdings Inc. stock benefits from AI revolutionQuarterly Profit Review & Risk Adjusted Buy and Sell Alerts - Newser
MTNB (Matinas BioPharma Holdings) Current Ratio : 3.78 (As of Sep. 2025) - GuruFocus
Matinas Biopharma Holdings Inc (MTNB) Performance and Fundamentals Dashboard tells a completely different story - Setenews
Matinas BioPharma CFO Keith Kucinski to step down in January By Investing.com - Investing.com Australia
Matinas BioPharma CFO Keith Kucinski to step down in January - Investing.com
Matinas Biopharma Holdings IncCFO Keith Kucinski resigns effective January 17, 2026SEC filing - MarketScreener
[8-K] Matinas BioPharma Holdings, Inc. Reports Material Event | MTNB SEC FilingForm 8-K - Stock Titan
Will Matinas BioPharma Holdings Inc. (6LJ0) stock split increase liquidity2025 Trade Ideas & Fast Exit and Entry Trade Guides - newser.com
Can Matinas Biopharma Holdings Inc. stock hold up in economic slowdown2025 EndofYear Setup & Safe Capital Allocation Plans - newser.com
Why institutional investors increase stakes in Matinas BioPharma Holdings Inc. (6LJ0) stockJuly 2025 Levels & Weekly Return Optimization Alerts - newser.com
What hedge fund moves indicate for Matinas Biopharma Holdings Inc. stock2025 Geopolitical Influence & Advanced Swing Trade Entry Plans - newser.com
Is Matinas BioPharma Holdings Inc. stock bottoming outWeekly Gains Report & Weekly Watchlist for Hot Stocks - newser.com
Why Matinas BioPharma Holdings Inc. stock could see breakout soonJuly 2025 Earnings & Expert Verified Movement Alerts - newser.com
Will Matinas BioPharma Holdings Inc. (6LJ0) stock see insider accumulationDividend Hike & AI Enhanced Trade Execution Alerts - newser.com
Matinas Biopharma Holdings, Inc. (MTNB) 8.04% in After-hours: Modest Price Recovery - Stocks Telegraph
Is Matinas Biopharma Holdings Inc. stock undervalued after correctionQuarterly Profit Report & High Conviction Buy Zone Alerts - newser.com
Matinas Biopharma Holdings Inc (MTNB) 財務データ
収益
当期純利益
現金流量
EPS
28.63%
大文字化:
|
ボリューム (24 時間):